Clinical Trial Update: Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design [Phase 3]

View source ↗

Summary

A Phase 3 factorial trial evaluating the safety and efficacy of linagliptin in combination with metformin in adults with Type 2 diabetes; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tradjenta (Linagliptin)
• metformin (metformin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2011-08-04